Table 2.
PBM therapy ameliorates mean maximum clinical disease score.
| Study | Mean maximum clinical score | |
|---|---|---|
| Control | EAE | |
| Goncalves et al. (27) | 3.5 ± 0.5 | 660 nm—2.5 ± 0.5 904 nm—2.5 ± 0.5 |
| Muili et al. (28) | 3.9 ± 0.2 NR 4.6 ± 0.2 |
Suppression protocol—3.6 ± 0.2 Onset protocol—not reported Double treatment protocol—2.2 ± 0.4 |
| Muili et al. (29) | 4.5 ± 0.1 | 3.6 ± 0.3 |
NR, not reported.